Back

Levosimendan improves the early prognosis of patients with Non ST-segment elevation myocardial infarction and Killip class > II

1 September 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in coronary artery disease: from bench to bedside (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Tianshu Gu

Tianjin (China)

6 More presentations in this session

Presentation thumbnail
Effects of rivaroxaban on vascular endothelial function and circulating endothelial progenitor cells: a randomized controlled trial
Ms M. Lin (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Exploring the long-term effects of dapagliflozin in patients with stable acute myocardial infarction and preserved ejection fraction through a propensity score matching study
Doctor B. Hsiao (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Restrictive versus liberal blood transfusion strategies in patients with myocardial infarction and anemia: individual patient data meta-analysis of randomized trials
Professor J. Carson (New Brunswick, US)
Abstract Slides Video
Presentation thumbnail
CSWT improves ventricular function by promoting angiogenesis through Rho/ROCK/ERK1/2 signal pathway in infarcted myocardium in rats
Professor Y. Wang (Kunming, CN)
Abstract Slides Video
Presentation thumbnail
Drug-coated balloon for de-novo coronary artery lesions exceeding 2.5 mm in diameter: optical coherence tomography analysis and clinical follow-up
Doctor L. Guo (Dalian, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in coronary artery disease: from bench to bedside (2)

The Event

Event poster

ESC Congress 2024

1 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
The short-term prognosis of salvianolate use during hospitalization in patients with acute myocardial infarction
thumbnail
Congress Presentation
The early use of inotropes, BB, SGLT2-i, ARNI and MRA in acute heart failure: the PENTA-HF observational study
thumbnail
Congress Presentation
Levosimendan in patients with cardiogenic shock refractory to dobutamine weaning

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources